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Abstract
Background: Detailed knowledge about viral respiratory disease transmission dynamics within healthcare institutions
is essential for effective infection control policy and practice. In the quest to study viral transmission pathways, we
aimed to investigate recruitment rates and adherence of healthcare workers (HCWs) and hospital inpatients with a
study protocol that involves prospective surveillance based on daily mid-turbinate nasal swabs and illness diaries.
Methods: Single center prospective surveillance of patients and HCWs in three different hospital departments of a
tertiary care center during an entire influenza season in Switzerland. Inpatients and acute care HCWs were asked to
provide mid-turbinate nasal swabs and illness diaries on a daily basis. Study protocol adherence and recruitment rates
were the primary outcomes of interest.
Results: A total 251 participants (59 (23.5%) health care workers and 192 (76.5%) inpatients) were recruited from three
different hospital wards. Recruitment rates differed between HCWs (62.1% of eligible HCWs) and inpatients (32.5%;
P < 0.001), but not within HCWs (P = 0.185) or inpatients (P = 0.301) of the three departments. The total number of
study-days was 7874; 2321 (29.5%) for inpatients and 5553 (70.5%) for HCWs. HCWs were followed for a median of 96
days (range, 71–96 days) and inpatients for 8 days (range, 3–77 days). HCWs provided swabs on 73% (range, 0–100%) of
study days, and diaries on 77% (range 0–100%). Inpatients provided swabs and diaries for 83% (range, 0–100%) of days
in hospital. In HCWs, increasing age, working in internal medicine and longer duration of total study participation were
positively associated with the proportion of swabs and diaries collected. Adherence to the study protocol was
significantly lower in physicians as compared to nurses for both swabs (P = 0.042) and diaries (P = 0.033). In inpatients,
no association between demographic factors and adherence was detected.
Conclusions Prospective surveillance of respiratory viral disease was feasible in a cohort of inpatients and HCWs over
an entire influenza season, both in terms of recruitment rates and adherence to a study protocol that included daily
specimen collection and illness diaries.
Trial registration: clinicaltrials.gov NCT02478905. Date of registration June 23, 2015.
Keywords: Influenza, Transmission, Asymptomatic infection, Surveillance, Healthcare-associated infection
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: stefan.kuster@usz.ch
†Alexandra Trkola and Stefan P. Kuster contributed equally to this work.
1Division of Infectious Diseases and Hospital Epidemiology, University
Hospital and University of Zurich, Raemistrasse 100 / HAL14 D6, 8091 Zürich,
Switzerland
Full list of author information is available at the end of the article
Schwarz et al. BMC Infectious Diseases          (2019) 19:446 
https://doi.org/10.1186/s12879-019-4057-5
Background
Influenza remains the most common infectious disease
cause of death in the developed world, causing up to 5′
000 hospitalizations and 1′500 deaths in Switzerland an-
nually [1]. Elderly persons, young children and persons
with underlying medical conditions are at highest risk
for adverse outcomes [2]. Despite barrier protection
measures and vaccination campaigns among healthcare
workers (HCWs), nosocomial acquisition of influenza is
a well-known patient safety issue, and outbreaks of influ-
enza are common in both acute and long-term care [3–8].
The epidemiology and transmission dynamics of influ-
enza in hospitals, however, are poorly understood. In
particular, it is not known how often asymptomatic or
minimally symptomatic persons may transmit disease
[9, 10]. This poses a problem because one-in-three influ-
enza infections are thought to be asymptomatic [11]. If
asymptomatic persons transmit influenza, vaccination of
patients and HCWs before start of the influenza season,
the permanent use of masks by HCWs during influenza
season, and quarantine for previously exposed inpatients
may be the only available measures to reduce the number
of influenza transmission events in acute care hospitals
[12–14]. Bridging this knowledge gap would be of major
benefit to infection prevention and control recommenda-
tions, and may result in reduced morbidity and mortality
associated with influenza in hospitals. Studying the ques-
tion whether asymptomatic individuals transmit influenza
virus in acute care, however, requires close monitoring of
a tight group of HCWs and patients with a high participa-
tion rate and adherence to a study protocol that comprises
close monitoring of disease activity, symptoms and con-
tacts between individuals.
To define whether exposure to asymptomatic subjects
with influenza infection constitutes a risk for influenza
virus transmission in an acute care hospital setting, we
designed the TransFLUas study, an active, prospective
surveillance study of HCWs and inpatients. We col-
lected mid-turbinate nasal swabs and influenza-like ill-
ness symptom diaries on a daily basis on dedicated study
wards over an entire influenza season, with the goal to
assess influenza transmission pathways in relation to in-
fluenza symptoms. In this report, we describe participant
recruitment and adherence to the protocol during the
2015/2016 influenza season.
Methods
Study setting, design and procedures
We performed a single center prospective surveillance
study of HCWs and inpatients in three different hospital
units (pulmonology, hematology and internal medicine)
at the University Hospital Zurich over the 2015/2016 in-
fluenza season. The University Hospital Zurich is a 900
beds university-affiliated tertiary care center that covers
all specialties except orthopedic surgery and pediatrics.
It serves a population of 400′000 inhabitants for primary
and 1′443’000 for tertiary care [15].
We followed patients in these 3 units, as well as nurs-
ing staff (nurses and assistant nurses), corporate hospi-
tality staff with direct patient contact and medical staff
(attending physicians and those in training) working on
the same wards during the influenza season. Influenza
season was considered to start when Swiss national sen-
tinel surveillance levels exceeded the national threshold
for an influenza epidemic and ended when influenza
levels fell below the epidemic threshold for two consecu-
tive weeks. (https://www.bag.admin.ch/bag/de/home/
krankheiten/ausbrueche-epidemien-pandemien/aktuelle-
ausbrueche-epidemien/saisonale-grippe---lagebericht-sch
weiz.html). All HCWs and inpatients ≥18 years of age on
the ward under surveillance were eligible for the study.
HCWs were excluded if they planned to spend more
than two consecutive weeks outside of Switzerland dur-
ing the influenza season in order to secure consistency
over time. HCWs were recruited by study personnel at
staff meetings prior to the influenza season. Patients
were approached by study personnel upon admission to
the participating study ward. Patients who were not
competent to consent were excluded. Participants were
not compensated for study participation.
HCWs were asked to complete a baseline demo-
graphic questionnaire, asking about personal data
(age, sex), household characteristics that may be asso-
ciated with reduced (e.g. having received seasonal
influenza vaccine, influenza vaccination history) or
increased (e.g. household crowding index (defined as
the number of people per household divided by
the number of bedrooms), living with children in
their household) risk of influenza, and underlying
medical conditions (Charlson comorbidity index) and
long-term medication [16]. A questionnaire was filled
in for inpatients upon enrollment, covering baseline
characteristics, including age, sex, date of admission,
vaccination status and co-morbidities (Charlson
comorbidity index). Length of hospital stay was
calculated from discharge and admission dates after
hospital discharge.
In consenting inpatients, study nurses collected
mid-turbinate nasal swabs daily from the day of enroll-
ment until discharge and filled in diaries covering signs
and symptoms of influenza infection (including cough,
sore throat, fever ≥38.0 °C, nasal congestion, weakness,
headache, loss of appetite or myalgia) and contacts with
other subjects with influenza symptoms. Patients were
asked to self-collect swabs and fill in daily diaries for 2
days after discharge and send the items back to the
study office. HCWs were asked to self-collect mid-tur-
binate nasal swabs and to fill in the illness diaries on a
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daily basis (including days off work) and drop the items
in an inbox placed on each study ward. The
self-collection of flocked mid-turbinate nasal swabs has
been shown to be comparable to nasopharyngeal aspi-
rates in children and adults [17–19]. Updates on the
current status of the influenza epidemic and reminders
to continue sending in swabs and diaries were sent to
participating HCWs by email each week.
Definitions
Recruitment rate was defined as the number of consent-
ing individuals divided by the number of eligible HCWs
and inpatients, respectively.
We defined adherence with the study protocol for
each study participant as the number of swabs and ill-
ness diaries, respectively, that were submitted in relation
to the number of samples/diary entries that the study
participant was expected to submit based on the study
protocol.
Statistical analysis
Categorical data were tested for differences using Fisher
exact tests, whereas continuous variables were tested
using Wilcoxon rank sum tests or the Student’s t test, as
appropriate. Multivariable linear regression analysis was
used to determine predictors for adherence to the study
protocol. Potential predictors among participant charac-
teristics were considered for inclusion in multivariable
models based on clinical judgment and previous hypoth-
eses, with final models representing those that best bal-
anced parsimony and fit. Data were analysed using Stata®
version 13.1 (Stata Corporation, College Station, TX).
Two-tailed P-values < 0.05 were considered statistically
significant.
Results
Recruitment
In total, 251 participants, including 59 (23.5%) HCWs
and 192 (76.5%) inpatients were enrolled in the study.
Overall, 192 out of 591 (32.5%) eligible patients could be
recruited, and 59/95 (62.1%) HCWs participated in the
study (P < 0.001) (see Table 1). Recruitment rates did not
differ between the three departments for either HCWs or
inpatients.
Healthcare worker and patient characteristics
HCWs and patient characteristics are shown in Tables 2
and 3, respectively. HCWs had a median age of 30.5
(range, 18.0–58.0) years and 50 (84.7%) were female.
The median household crowding index was 1.3 (range,
0.5–3), and 11 (18.6%) had children < 18 years of age in
their household. There were no significant differences in
demographic or other characteristics between HCWs
from the three different study wards.
We enrolled 192 patients with a median age of 57.9
years (range, 18.3–94.1), and an overall median Charlson
comorbidity index of 2 (range 0–8) (Table 3). Patients
from the internal medicine ward were older than others
and more likely to have peripheral vascular disease or
diabetes, whereas patients with chronic pulmonary dis-
ease were more likely to be hospitalized on the pulmo-
nology ward and patients with leukemia were almost
exclusively admitted to the hematology ward.
Adherence to the study protocol
Table 4 shows the adherence to the study measures in
HCWs and inpatients. In total, 7874 study-days were re-
corded, 2321 (29.5%) for inpatients and 5553 (70.5%) for
HCWs. The median number of study-days was 96
(range, 71–96) for HCWs and 8 (range, 3–77) for inpa-
tients. The median number of HCW- or patient-days did
not differ between the study wards.
A total of 1469 mid-turbinate nasal swabs (median, 5;
range, 0–68) were collected from participating inpa-
tients, 1430 (97.3%) during hospitalization (median, 4;
range, 0–68) and 39 (2.7%) after discharge. Twenty-
seven (14.1%) inpatients provided swabs after hospital
discharge. The median percentage of eligible swabs sub-
mitted per day in hospital was 83% (range, 0–100%) and
did not differ between the three study wards. There was
no association of adherence to the study protocol with
age, sex, underlying comorbidities, ward or duration of
participation in the study (data not shown).
HCWs self-collected a total of 3513 swabs (median,
69; range, 0–96). The median proportion of swabs per
day in study among HCWs was 73% (range, 0–100%)
and of diaries 77% (range 0–100%). Multivariable linear
regression analysis revealed increasing age (P = 0.001),
working in internal medicine as compared to pulmonol-
ogy (P = 0.019) and longer duration of total study partici-
pation to be positively associated with the proportion of
swabs collected. The same predictors were found for ad-
herence with filling in study diaries (data not shown).
Adherence to the study protocol was significantly lower
in physicians as compared to nurses for both collecting
swabs (median number of swabs per day: 46% (range,
0–96%) in physicians vs. 78% (range, 0–100%) in
nurses, P = 0.042) and study diaries (median number
of diaries per day: 47% (range, 0–97%) in physicians
vs. 81% (range, 0–100%) in nurses, P = 0.033).
Figure 1 depicts the total number of swabs and diaries
collected in HCWs (panel A) and inpatients (panel B) per
calendar week. Given that the number of enrolled HCWs
was stable over time, a marked decrease in the number of
swabs and diaries could be detected after 9 weeks of study
data collection, reflecting a decrease in protocol adher-
ence. In hospitalized patients, however, such a decreasing
trend in the number of samples was not observed.
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Table 2 Healthcare worker characteristics on wards with active surveillance for influenza, University Hospital Zurich, 2015/16
influenza season
Characteristic Department
All departments
(n = 59)1
Pulmonology
(n = 17)
Hematology
(n = 19)
Internal medicine
(n = 22)
P-value
Age, years, median (range) 30.5 (18.0–58.0) 30.5 (18.5–51.6) 31.1 (21.5–58.0) 26.7 (18.0–51.9) 0.52
Female sex 50 (84.7) 14 (82.4) 17 (89.5) 19 (86.4) 0.45
Profession
Nurse 49 (83.1) 13 (76.5) 15 (79.0) 21 (95.5) 0.27
Physician 9 (15.3) 3 (17.7) 4 (21.1) 1 (4.6)
Other 1 (1.7) 1 (5.9) 0 (0) 0 (0)
Charlson comorbidity index, median (range) 0 (0–1) 0 (0–1) 0 (0–0) 0 (0–1) 0.88
Myocardial infarction 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Congestive cardiac insufficiency 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Peripheral vascular disease 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Chronic pulmonary disease 2 (3.4) 1 (5.9) 0 (0) 1 (4.6) 0.59
Conjuctive tissue disease 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Diabetes without complications 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Peptic ulcer disease 1 (1.7) 0 (0) 0 (0) 1 (4.6) 0.44
Chronic disease of the liver or cirrhosis 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Hemiplegia 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Moderate or severe kidney disease 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Diabetes with chronic complications 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Solid organ malignancy 0 (0) 0 (0) 0 (0) 0 (0) n.a
Leukemia 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Lymphoma 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Moderate or severe liver disease 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Malignant tumor, metastasis 0 (0) 0 (0) 0 (0) 0 (0) n.a.
AIDS 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Dementia 0 (0) 0 (0) 0 (0) 0 (0) n.a.
Household crowding index, median (range) 1.3 (0.5–3) 1.3 (1–2.5) 1.3 (1–2) 1.3 (0.5–3) 0.99
Children (< 18 years) in household 11 (18.6) 5 (22.7) 1 (5.3) 5 (22.7) 0.24
Data are n (%), unless indicated otherwise. 1Sum of HCWs of different departments does not equal total number as one HCW worked on all wards and thus was
not assigned to one single department
Abbreviations: n.a. not applicable, AIDS acquired immunodeficiency syndrome
Table 1 Recruitment rates of patients and healthcare workers enrolled in prospective surveillance of influenza infection, University
Hospital Zurich, 2015/2016 influenza season
Participants Department
All departments Pulmonology Hematology Internal medicine P-value
Patients 192/591 (32) 80/263 (30) 56/179 (31) 56/149 (38) 0.3
HCWs 59/95 (62) 19/33 (52) 17/33 (58) 22/29 (76) 0.18
Nurses 49 15 13 21
Physicians1 9 3 4 1
Other HCWs2 1 1 0 0
Data are n (%). 1one HCW was working on all three wards. 2one HCW from corporate hospitality
Abbreviations: HCWs healthcare workers
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Discussion
In a prospective surveillance study of asymptomatic and
symptomatic influenza infection conducted on three
wards of a large university hospital during the influenza
season 2015/2016, we were able to recruit 32% of inpa-
tients and 62% of HCWs. HCWs provided self-collected
swabs on 73% of all study days and illness diaries on
77%, whereas swabs and diaries could be obtained from
inpatients in 83% of hospital days. Adherence to the
study protocol after discharge was poor in hospitalized
patients. Physicians provided a lesser proportion of
swabs and diaries than nurses, and higher age, working
in internal medicine and longer duration of participation
were associated with better adherence among HCWs.
Whereas the total self-collected swabs and diaries de-
creased over time in HCWs, adherence to the protocol
was stable over time in hospitalized patients.
We were unable to locate any other study that
followed cohorts of inpatients and HCWs on dedicated
wards over one influenza season with the request to pro-
vide nasal swabs and diaries routinely irrespective of
symptoms. Although our design is unique, we consider
adherence to both illness diaries and swabs in more than
75% of study-days satisfying, which is supported by other
authors who suggest to aim for response rates of at least
60% in surveys performed on a single point in time [20].
The high coverage in daily swabs and diaries highlights
that, even considering decrease in adherence amongst
HCW observed in later study periods, the majority of
shedders must have been captured as influenza symp-
toms and viral shedding usually last more than a single
day [21].
Although the problem of non-adherence in clinical tri-
als is quite common for multiple reasons, [22] it can be
improved by focusing on protocols and processes, even
if they seem peripheral [23]. Frost et al. emphasize
the importance of favorable trial conditions and
organizational context, which can influence the qual-
ity of diary data collected [24]. We believe that daily
presence of our study team on study wards together
with a simple diary and high motivation of participat-
ing HCWs helped to achieve high adherence rates in
our study despite its long duration. One other favorable
factor may be the staffing conditions in our institution. It
has a relatively high number of physicians and nurses per
100 hospitalizations compared to other institutions in our
Table 3 Patient characteristics
Characteristic Department
All departments
(n = 192)
Pulmonology
(n = 80)
Hematology
(n = 56)
Internal medicine
(n = 56)
P-value
Age, years, median (range) 57.9 (18.3–94.1) 54.6 (18.3–79.5) 55.9 (21.0–87.6) 62.2 (29.4–94.2) 0.002
Female sex 80 (41.6) 32 (40) 25 (44.6) 23 (41) 0.86
Charlson comorbidity index, median (range) 2 (0–8) 1 (0–8) 2 (0–6) 2 (0–7) 0.15
Myocardial infarction 10 (5.2) 3 (3.7) 3 (5.4) 4 (7.1) 0.71
Congestive cardiac insufficiency 16 (8.3) 7 (8.7) 1 (1.8) 8 (14.2) 0.13
Peripheral vascular disease 12 (6.2) 2 (2.5) 1 (1.8) 9 (16) 0.006
Chronic pulmonary disease 78 (40.6) 64 (80) 5 (8.9) 9 (16) < 0.001
Conjuctive tissue disease 0 0 0 0 n.a
Diabetes without complications 27 (14) 11 (13.7) 2 (3.6) 14 (25) 0.017
Peptic ulcer disease 2 (1) 1 (1.2) 0 1 (1.8) 0.50
Chronic disease of the liver or cirrhosis 3 (1.6) 0 0 3 (5.4) 0.07
Hemiplegia 2 (1) 1 (1.2) 0 1 (1.8) 0.67
Moderate or severe kidney disease 22 (11.5) 11 (13.7) 4 (7.1) 7 (12.5) 0.47
Diabetes with chronic complications 6 (3.1) 1 (1.2) 0 5 (8.9) 0.035
Solid organ malignancy 12 (6.2) 4 (5) 1 (1.8) 7 (12.5) 0.054
Leukemia 20 (10.4) 1 (1.2) 19 (33.9) 0 < 0.001
Lymphoma 7 (3.6) 1 (1.2) 5 (8.9) 1 (1.8) 0.10
Moderate or severe liver disease 16 (8.3) 7 (8.7) 4 (7.1) 5 (8.9) 0.81
Malignant tumor, metastasis 5 (2.6) 4 (5) 0 1 (1.8) 0.30
AIDS 2 (1) 0 1 (1.8) 1 (1.8) 0.49
Dementia 1 (0.5) 1 (1.2) 0 0 0.59
Data are n (%), unless indicated otherwise
Abbreviations: n.a. not applicable, AIDS acquired immunodeficiency syndrome
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Table 4 Adherence to study requirements (collection of swabs and diaries on a daily basis) of patients and healthcare worker enrolled
in prospective surveillance of influenza infection, 2015/2016 influenza season
Department
All departments Pulmonology Hematology Internal Medicine P-value
Days in study
Total patients 2321 920 788 613 n.a.
Median days in study per patient, range 8 (3–77) 9 (3–77) 8 (3–65) 8 (3–34) 0.83
Total HCWs 5553 1587 1774 2096 n.a
Median days in study per HCW, range 96 (71–96) 96 (71–96) 96 (79–96) 96 (80–96) 0.45
Nurses 96 (93–96) 96 (94–96) 96 (93–96) 96 (96–96) 0.91
Physicians 82 (71–96) 82 (71–92) 85 (79–88) 80 (80–80) 0.79
Swabs
Patients
Total number of swabs in study 1469 592 471 406 n.a.
Median number of swabs per patient, range 5 (0–68) 4.5 (0–68) 5 (0–49) 5 (0–26) 0.84
Total number of swabs in hospital 1430 568 461 401 n.a.
Median number of swabs abs in hospital, range 4 (0–68) 4 (0–68) 5 (0–49) 5 (0–26) 0.73
Total number of swabs after discharge 39 24 10 5 n.a.
Median number of swabs after discharge, range 0 (0–4) 0 (0–4) 0 (0–3) 0 (0–2) 0.53
Swabs per day in study, % 60 (0–100) 60 (0–100) 60 (0–100) 60 (0–90) 0.86
Swabs per day in hospital, % 83 (0–100) 80 (0–100) 84 (0–100) 85 (0–100) 0.97
HCWs
Total number of swabs in study 3513 787 1244 1390 n.a
Median number of swabs in study, range 69 (0–96) 42 (0–96) 69 (18–96) 77.5 (0–92) 0.29
Swabs per day in study, % 62 (0–100) 49 (0–100) 70 (20–100) 66 (0–96) 0.26
Nurses
Total number of swabs in study 3150 694 1066 1390 n.a
Median number of swabs in study, range 75 (0–96) 65 (0–96) 71 (22–96) 78 (8–92) 0.56
Swabs per day in study, % 67 (0–100) 56 (0–100) 74 (23–100) 69 (8–96) 0.56
Physicians
Total number of swabs in study 339 69 178 0 n.a
Median number of swabs in study, range 36 (0–92) 27 (0–42) 48.5 (18–63) 0 0.25
Swabs per day in study, % 43 (0–96) 26 (0–46) 53 (20–74) 0 0.25
Diaries
Patients
Total number of diaries in study 1470 593 471 406 n.a.
Median number of diaries in study, range 5 (0–68) 4.5 (0–68) 5 (0–49) 5 (0–26) 0.85
Total number of diaries in hospital, total 1431 569 461 401 n.a
Median number of diaries in hospital, range 4 (0–68) 4 (0–68) (0–49) 5 (0–26) 0.75
Total number of diaries after discharge, total 39 24 10 5 n.a
Median number of diaries after discharge, range 0 (0–4) 0 (0–4) 0 (0–3) 0 (0–2) 53
Diaries per day in study, % 60 (0–100) 60 (0–100) 60 (0–100) 60 (0–90) 0.86
Diaries per day in hospital, % 83 (0–100) 80 (0–100) 84 (0–100) 85 (0–100) 0.97
HCWs
Total number of diaries in study 3661 849 1275 1444 n.a.
Median number of diaries in study, range 72 (0–96) 49 (0–96) 72 (18–96) 83 (0–94) 0.30
Diaries per day in study, % 77 (0–100) 53 (0–100) 77 (20–100) 86 (0–98) 0.27
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country, [25] and, as a university hospital, is experienced
with clinical studies. The Swiss health system belongs to
the five highest ranked countries with regard to personal
health care access and quality, [26] which may also explain
the high adherence rate, especially in an academic setting.
Our HCWs may have more resources that allow them to
participate in research activities. Barriers for adherence
may have been the long study duration for HCWs with
the need to remember swab collection and diary comple-
tion also during days off work and the efforts needed for
patients to send the study materials back to the study of-
fice after discharge, in addition to differences in perceived
importance of the need for full adherence to the protocol.
Our study has several strengths. In a well-defined study
population within a single center, we were able to enroll
and follow a substantial proportion of patients and HCWs
over an entire influenza season. The critical proportion of
participants, however, to detect influenza transmission
events, has not been defined, and therefore a larger num-
ber of participants with higher adherence rates to the
study protocol would certainly increase the probability of
detecting influenza transmissions, especially from asymp-
tomatic subjects. Nevertheless, incomplete data collection
may still be adequate to address the question of detection
of asymptomatic influenza transmission, as influenza virus
shedding is expected to last for several days [27, 28]. The
best adherence to the protocol was observed in the first
half of the study period, and as influenza activity is usually
high during the first four to 6 weeks of an influenza sea-
son, the decline in adherence to the study protocol to-
wards the end of the study period is of lower significance
(https://www.bag.admin.ch/bag/de/home/krankheiten/
ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-
epidemien/saisonale-grippe---lagebericht-schweiz.html).
Nevertheless, the risk of missing transmission events dur-
ing the later stage of the season may be higher.
Table 4 Adherence to study requirements (collection of swabs and diaries on a daily basis) of patients and healthcare worker enrolled
in prospective surveillance of influenza infection, 2015/2016 influenza season (Continued)
Department
All departments Pulmonology Hematology Internal Medicine P-value
Nurses
Total number of diaries in study 3275 740 1091 1444 n.a
Median number of diaries in study, range 78 (0–96) 69 (0–96) 75 (24–96) 83 (8–94) 0.59
Diaries per day in study, % 81 (0–100) 73 (0–100) 78 (25–100) 86 (8–98) 0.57
Physicians
Total number of diaries in study 361 84 184 0 n.a
Median number of diaries in study, range 37 (0–93) 35 (0–49) 49 (18–68) 0 0.25
Diaries per day in study, % 47 (0–97) 43 (0–53) 60 (20–77) 0 0.25
Abbreviations: n.a. not applicable, HCWs healthcare workers
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Fig. 1 Number of swabs and illness diaries collected in healthcare workers and patients per calendar week, influenza season 2015/16
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One limitation of our study is generalizability, as it
was performed in specific wards and departments of a
single university-affiliated institution in a high-income
country. Our cohort of HCWs is relatively small and pa-
tients are diverse. It remains unclear whether the same
recruitment rate and adherence can be observed in a dif-
ferent setting. We were not able to include all health
care providers: our study population was limited to
nurses, physicians and corporate hospitality staff work-
ing on the particular wards, and did not include other
providers (e.g. physiotherapists, consulting physicians)
who could also transmit influenza to study inpatients. In
addition, we were unable to include visitors, who may
also introduce influenza from the community.
Conclusions
In conclusion, our study provides proofs of concept that
it is possible to follow a cohort of both patients and
healthcare workers in an adult acute care hospital setting
and perform intensive surveillance for respiratory infec-
tions. The question whether this proportion of HCWs
and inpatients is sufficient to reliably detect transmission
events, especially from asymptomatic participants, re-
mains open and deserves further study. Based on our re-
sults, other investigators should be encouraged to
perform similar studies in order to investigate real-world
clinical questions about the transmission dynamics of in-
fluenza infection.
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